Key Takeaways
- • Thrive Therapies, a tech-enabled pediatric healthcare company, raised $7.7 million in funding led by LiveOak Ventures, according to a Business Wire announcement.
- • Activate Venture Partners and the Charter School Growth Fund participated in the round.
- • The company delivers therapy, evaluations and behavioral health care to students with disabilities in more than 200 schools and districts across six states.
- • Proceeds will fund expansion into new markets, growth of clinical teams, and advancement of its Thrive Clinical platform.
Summary
Dallas-based Thrive Therapies, a tech-enabled pediatric healthcare company, announced $7.7 million in funding led by LiveOak Ventures, according to a Business Wire release. Activate Venture Partners and the Charter School Growth Fund also participated in the round.
The company delivers therapy, evaluations and behavioral health care to students with disabilities in more than 200 schools and districts across six states. Its model embeds clinical services directly within school settings, positioning it as an in-school alternative to standalone outpatient pediatric care.
According to the announcement, the company will use the capital to expand into new markets, grow its clinical teams, and advance its Thrive Clinical technology platform. The release was the primary source available for this summary; the full article text was not accessible, so additional financial terms, valuation, and detailed operating metrics are not reported here.
The company delivers therapy, evaluations and behavioral health care to students with disabilities in more than 200 schools and districts across six states. Its model embeds clinical services directly within school settings, positioning it as an in-school alternative to standalone outpatient pediatric care.
According to the announcement, the company will use the capital to expand into new markets, grow its clinical teams, and advance its Thrive Clinical technology platform. The release was the primary source available for this summary; the full article text was not accessible, so additional financial terms, valuation, and detailed operating metrics are not reported here.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.